Warning: The NCBI web site requires JavaScript to function. more...
Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA.
Friew YN, Boyko V, Hu WS, Pathak VK.
Retrovirology. 2009 Jun 4;6:56.
Related citations
Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.
Svarovskaia ES, Xu H, Mbisa JL, Barr R, Gorelick RJ, Ono A, Freed EO, Hu WS, Pathak VK.
J Biol Chem. 2004 Aug 20;279(34):35822-8. Epub 2004 Jun 20.
APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA.
Russell RA, Moore MD, Hu WS, Pathak VK.
Retrovirology. 2009 Feb 13;6:16.
RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1.
Huthoff H, Autore F, Gallois-Montbrun S, Fraternali F, Malim MH.
PLoS Pathog. 2009 Mar;5(3):e1000330. Epub 2009 Mar 6.
Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.
Ao Z, Yu Z, Wang L, Zheng Y, Yao X.
PLoS One. 2008 Apr 16;3(4):e1995.
Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration.
Mbisa JL, Barr R, Thomas JA, Vandegraaff N, Dorweiler IJ, Svarovskaia ES, Brown WL, Mansky LM, Gorelick RJ, Harris RS, Engelman A, Pathak VK.
J Virol. 2007 Jul;81(13):7099-110. Epub 2007 Apr 11.
Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G.
Iwatani Y, Chan DS, Wang F, Maynard KS, Sugiura W, Gronenborn AM, Rouzina I, Williams MC, Musier-Forsyth K, Levin JG.
Nucleic Acids Res. 2007;35(21):7096-108. Epub 2007 Oct 16.
Human immunodeficiency virus type 1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1.
Watashi K, Khan M, Yedavalli VR, Yeung ML, Strebel K, Jeang KT.
J Virol. 2008 Oct;82(20):9928-36. Epub 2008 Aug 6.
Live cell visualization of the interactions between HIV-1 Gag and the cellular RNA-binding protein Staufen1.
Milev MP, Brown CM, Mouland AJ.
Retrovirology. 2010 May 10;7:41.
APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker.
Burnett A, Spearman P.
J Virol. 2007 May;81(10):5000-13. Epub 2007 Mar 7.
7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G.
Wang T, Tian C, Zhang W, Luo K, Sarkis PT, Yu L, Liu B, Yu Y, Yu XF.
J Virol. 2007 Dec;81(23):13112-24. Epub 2007 Sep 19.
Inhibition of HIV-1 infection and replication by enhancing viral incorporation of innate anti-HIV-1 protein A3G: a non-pathogenic Nef mutant-based anti-HIV strategy.
Green LA, Liu Y, He JJ.
J Biol Chem. 2009 May 15;284(20):13363-72. Epub 2009 Mar 26.
Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C.
Wang T, Zhang W, Tian C, Liu B, Yu Y, Ding L, Spearman P, Yu XF.
Virology. 2008 Jul 20;377(1):71-9. Epub 2008 May 21.
Functional domain organization of human APOBEC3G.
Gooch BD, Cullen BR.
Virology. 2008 Sep 15;379(1):118-24. Epub 2008 Jul 18.
HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain.
Iwatani Y, Chan DS, Liu L, Yoshii H, Shibata J, Yamamoto N, Levin JG, Gronenborn AM, Sugiura W.
Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19539-44. Epub 2009 Nov 3.
APOBEC3G complexes decrease human immunodeficiency virus type 1 production.
Martin KL, Johnson M, D'Aquila RT.
J Virol. 2011 Sep;85(18):9314-26. Epub 2011 Jul 13.
Regulation of Vif mRNA splicing by human immunodeficiency virus type 1 requires 5' splice site D2 and an exonic splicing enhancer to counteract cellular restriction factor APOBEC3G.
Mandal D, Exline CM, Feng Z, Stoltzfus CM.
J Virol. 2009 Jun;83(12):6067-78. Epub 2009 Apr 8.
Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.
Russell RA, Smith J, Barr R, Bhattacharyya D, Pathak VK.
J Virol. 2009 Feb;83(4):1992-2003. Epub 2008 Nov 26.
Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions.
Xu H, Chertova E, Chen J, Ott DE, Roser JD, Hu WS, Pathak VK.
Virology. 2007 Apr 10;360(2):247-56. Epub 2006 Nov 28.
Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization.
Khan MA, Goila-Gaur R, Kao S, Miyagi E, Walker RC Jr, Strebel K.
Retrovirology. 2009 Nov 3;6:99.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on